Skip to main content
Institute for Global Health & Infectious Diseases

1999-2009

  1. Fetzer BC, Hosseinipour MC, Kamthuzi P, et al. Predictors for mortality and loss to follow-up among children receiving anti-retroviral therapy in Lilongwe, Malawi. Trop Med Int Health. Aug 2009;14(8):862-869.
  2. van Oosterhout JJ, Brown L, Weigel R, et al. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria. Trop Med Int Health. Aug 2009;14(8):856-861.
  3. Hosseinipour MC, van Oosterhout JJ, Weigel R, et al. The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. AIDS. Jun 1 2009;23(9):1127-1134.
  4. Ferguson YO, Eng E, Bentley M, et al. Evaluating nurses’ implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, Malawi. AIDS Educ Prev. Apr 2009;21(2):141-155.
  5. van der Horst C, Chasela C, Ahmed Y, et al. Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi. Contemp Clin Trials. Jan 2009;30(1):24-33.
  6. Kafulafula G, Mwatha A, Chen YQ, et al. Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa. Pediatrics. Jul 2009;124(1):e137-144.
  7. Samuel JC, Akinkuotu A, Villaveces A, et al. Epidemiology of injuries at a tertiary care center in Malawi. World J Surg. Sep 2009;33(9):1836-1841.
  8. Keiser O, Anastos K, Schechter M, et al. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health. Jul 2008;13(7):870-879.
  9. Robertson K, Kopnisky K, Hakim J, et al. Second assessment of NeuroAIDS in Africa. J Neurovirol. Apr 2008;14(2):87-101.
  10. Braitstein P, Boulle A, Nash D, et al. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health (Larchmt). Jan-Feb 2008;17(1):47-55.
  11. Hoffman IF, Martinson FE, Powers KA, et al. The year-long effect of HIV-positive test results on pregnancy intentions, contraceptive use, and pregnancy incidence among Malawian women. J Acquir Immune Defic Syndr. Apr 1 2008;47(4):477-483.
  12. Hosseinipour M, Weigel R, van Oosterhout J, Kumwenda J, Mzinganjira D, Mhango B, Phiri R, Phiri S. Validating Clinical and Immunological Definitions of Antiretroviral Treatment Failure in Malawi. Paper presented at: 4th IAS Conference on HIV pathogenesis, Treatment and Prevention2007; Sydney.
  13. Brinkhof MW, Egger M, Boulle A, et al. Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries. Clin Infect Dis. Dec 1 2007;45(11):1518-1521.
  14. Hosseinipour MC, Napravnik S, Joaki G, et al. HIV and parasitic infection and the effect of treatment among adult outpatients in Malawi. J Infect Dis. May 1 2007;195(9):1278-1282.
  15. Hosseinipour MC, Corbett AH, Kanyama C, et al. Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults. AIDS. Jan 2 2007;21(1):59-64.
  16. Hosseinipour MC, Neuhann FH, Kanyama CC, et al. Lessons learned from a paying antiretroviral therapy service in the public health sector at Kamuzu Central Hospital, Malawi: 1-year experience. J Int Assoc Physicians AIDS Care (Chic Ill). Sep 2006;5(3):103-108.
  17. Safren SA, Kumarasamy N, Hosseinipour M, et al. Perceptions about the acceptability of assessments of HIV medication adherence in Lilongwe, Malawi and Chennai, India. AIDS Behav. Jul 2006;10(4):443-450.
  18. Kourtis AP, Bramson B, van der Horst C, et al. Low absolute neutrophil counts in african infants. J Int Assoc Physicians AIDS Care (Chic Ill). Jul 2005;4(3):73-76.
  19. Hosseinipour MC, Kazembe PN, Sanne IM, van der Horst CM. Challenges in delivering antiretroviral treatment in resource poor countries. AIDS. 2002;16 Suppl 4:S177-187.
  20. Hosseinipour M, Cohen MS, Vernazza PL, Kashuba AD. Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1? Clin Infect Dis. May 15 2002;34(10):1391-1395.
  21. Moses A, Zimba C, Kamanga E, et al. Prevention of mother-to-child transmission: program changes and the effect on uptake of the HIVNET 012 regimen in Malawi. AIDS (London, England). Jan 2 2008;22(1):83-87.
  22. Chilongozi D, Wang L, Brown L, et al. Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania. Pediatr Infect Dis J. Sep 2008;27(9):808-814.
  23. Brown E, Chi BH, Read JS, et al. Determining an optimal testing strategy for infants at risk for mother-to-child transmission of HIV-1 during the late postnatal period. AIDS. Nov 12 2008;22(17):2341-2346.
  24. Chasela C, Chen YQ, Fiscus S, et al. Risk factors for late postnatal transmission of human immunodeficiency virus type 1 in sub-Saharan Africa. Pediatr Infect Dis J. Mar 2008;27(3):251-256.
  25. Pilcher CD, Joaki G, Hoffman IF, et al. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS (London, England). Aug 20 2007;21(13):1723-1730.
  26. Goldenberg RL, Andrews WW, Hoffman I, et al. Fetal fibronectin and adverse infant outcomes in a predominantly human immunodeficiency virus-infected African population: a randomized controlled trial. Obstet Gynecol. Feb 2007;109(2 Pt 1):392-401.
  27. Powers KA, Miller WC, Pilcher CD, et al. Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm. AIDS. Oct 18 2007;21(16):2237-2242.
  28. Fiscus SA, Pilcher CD, Miller WC, et al. Rapid, real-time detection of acute HIV infection in patients in Africa. J Infect Dis. Feb 1 2007;195(3):416-424.
  29. Taha TE, Brown ER, Hoffman IF, et al. A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. AIDS. Jun 12 2006;20(9):1313-1321.
  30. Potter D, Goldenberg RL, Read JS, et al. Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 Trial in Malawi, Tanzania, and Zambia. Sex Transm Dis. Oct 2006;33(10):604-609.
  31. Price MA, Cohen MS, Hoffman IF, Chilongozi D, Martinson FE, Tembo T. Collecting the essence of man: semen collection for HIV transmission studies in sub-Saharan Africa. Sexually transmitted infections. Apr 2005;81(2):185-186.
  32. Petch LA, Hoffman IF, Jere CS, et al. Genotypic analysis of the protease and reverse transcriptase of HIV type 1 subtype C isolates from antiretroviral drug-naive adults in Malawi. AIDS Res Hum Retroviruses. Sep 2005;21(9):799-805.
  33. Jere C, Cunliffe NA, Hoffman IF, et al. Plasma HIV burden in Malawian children co-infected with rotavirus. AIDS. Jul 27 2001;15(11):1439-1442.
  34. Henderson GJ, Hoffman NG, Ping LH, et al. HIV-1 populations in blood and breast milk are similar. Virology. Dec 5 2004;330(1):295-303.
  35. Kaydos SC, Swygard H, Wise SL, et al. Development and validation of a PCR-based enzyme-linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in women. J Clin Microbiol. Jan 2002;40(1):89-95.
  36. Dyer JR, Hoffman IF, Eron JJ, Jr., Fiscus SA, Cohen MS. Immune activation and plasma viral load in HIV-infected African individuals. AIDS. Jul 9 1999;13(10):1283-1285.
  37. Hoffman IF, Jere CS, Taylor TE, et al. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS. Mar 11 1999;13(4):487-494.
  38. Nelson JA, Loftis AM, Kamwendo D, et al. Nevirapine resistance in human immunodeficiency virus type 1-positive infants determined using dried blood spots stored for up to six years at room temperature. J Clin Microbiol. Apr 2009;47(4):1209-1211.